Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
27.13
+0.08 (0.28%)
Dec 3, 2024, 12:00 PM EST - Market open
Rigel Pharmaceuticals Market Cap
Rigel Pharmaceuticals has a market cap or net worth of $477.81 million as of December 3, 2024. Its market cap has increased by 238.39% in one year.
Market Cap
477.81M
Enterprise Value
515.58M
1-Year Change
238.39%
Ranking
Category
Stock Price
$27.13
Market Cap Chart
Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $477.81M, an increase of 87.45%. That is a compound annual growth rate of 2.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 2, 2024 | 476.50M | 88.49% |
Dec 29, 2023 | 252.80M | -2.51% |
Dec 30, 2022 | 259.30M | -42.78% |
Dec 31, 2021 | 453.20M | -23.37% |
Dec 31, 2020 | 591.40M | 64.87% |
Dec 31, 2019 | 358.70M | -6.42% |
Dec 31, 2018 | 383.30M | -32.57% |
Dec 29, 2017 | 568.40M | 141.36% |
Dec 30, 2016 | 235.50M | -12.19% |
Dec 31, 2015 | 268.20M | 34.57% |
Dec 31, 2014 | 199.30M | -20.02% |
Dec 31, 2013 | 249.20M | -55.93% |
Dec 31, 2012 | 565.50M | 0.60% |
Dec 30, 2011 | 562.10M | 43.14% |
Dec 31, 2010 | 392.70M | -20.31% |
Dec 31, 2009 | 492.80M | 68.36% |
Dec 31, 2008 | 292.70M | -62.86% |
Dec 31, 2007 | 788.20M | 164.67% |
Dec 29, 2006 | 297.80M | 47.43% |
Dec 30, 2005 | 202.00M | -57.71% |
Dec 31, 2004 | 477.70M | 68.26% |
Dec 31, 2003 | 283.90M | 465.54% |
Dec 31, 2002 | 50.20M | -71.28% |
Dec 31, 2001 | 174.80M | -51.24% |
Dec 29, 2000 | 358.50M | 40.64% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Arcturus Therapeutics Holdings | 496.78M |
KalVista Pharmaceuticals | 495.11M |
REGENXBIO | 491.49M |
Xeris Biopharma Holdings | 488.99M |
Korro Bio | 487.71M |
Cartesian Therapeutics | 478.56M |
Sonida Senior Living | 478.13M |
Celcuity | 475.26M |